Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

101885

	registered interest
	date	30/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when his Department will publish guidance on the timeline for a successor to the National Dementia Strategy for England and the Prime Minister's Challenge on Dementia.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	212582
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>The Department has established a new time-limited Stakeholder Advisory Group to help inform the next phase of work on dementia, post the current Prime Minister’s Challenge on Dementia, which superseded the National Dementia Strategy and which is due to end in March 2015.</p><p> </p><p> </p><p> </p><p>The Advisory Group is providing advice to help inform the Department’s work to shape the future direction of domestic dementia policy to 2020. The group met for the first time on 17 October to discuss their draft terms of reference for the proposed work programme and timeline.</p><p> </p><p> </p><p> </p><p>Once finalised the terms of reference for the group and other details including the envisaged timeline for the work will be published on the Department of Health’s Prime Ministers Challenge website.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 212685 question first answered 06/11/2014 13:31:29 answering member 1439 label Biography information for Norman Lamb
	tabling member	4022 label Biography information for Oliver Colvile

101912

	registered interest
	date	30/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when his Department expects to announce the timetable for developing a successor strategy to the National Dementia Strategy for England and the Prime Minister's Challenge on Dementia.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	212685
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>The Department has established a new time-limited Stakeholder Advisory Group to help inform the next phase of work on dementia, post the current Prime Minister’s Challenge on Dementia, which superseded the National Dementia Strategy and which is due to end in March 2015.</p><p> </p><p> </p><p> </p><p>The Advisory Group is providing advice to help inform the Department’s work to shape the future direction of domestic dementia policy to 2020. The group met for the first time on 17 October to discuss their draft terms of reference for the proposed work programme and timeline.</p><p> </p><p> </p><p> </p><p>Once finalised the terms of reference for the group and other details including the envisaged timeline for the work will be published on the Department of Health’s Prime Ministers Challenge website.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 212582 question first answered 06/11/2014 13:31:29 answering member 1439 label Biography information for Norman Lamb
	tabling member	4022 label Biography information for Oliver Colvile

101915

	registered interest
	date	30/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what detailed assessments he has made of the effectiveness of the National Dementia Strategy; and if he will publish the full results of that assessment.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	212686
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>While the Department has not undertaken a detailed assessment of the effectiveness of the National Dementia Strategy, it has commissioned an independent assessment of the improvements in dementia care and support since 2009, which incorporates the progress made under both the National Dementia Strategy (2009-14) and the current Prime Minister’s Challenge on Dementia. The National Dementia Strategy was superseded by the Prime Minister's Challenge on Dementia launched in 2012, which builds on and takes forward at pace the work commenced as part of the National Dementia Strategy. The Prime Minister's Challenge concludes at the end of March 2015.</p><p> </p><p> </p><p> </p><p>The National Dementia Strategy has been the subject of more detailed work by the All Party Parliamentary Group (APPG) on Dementia and other organisations this year, which is being used to inform the Department’s work on the future of dementia care and support. The APPG published a report in May 2014, ‘Building on the National Dementia Strategy: Change, progress and priorities’.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 212671 question first answered 06/11/2014 15:27:13 answering member 1439 label Biography information for Norman Lamb
	tabling member	4022 label Biography information for Oliver Colvile

101923

	registered interest
	date	30/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether an official review of the National Dementia Strategy has taken place.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	212671
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>While the Department has not undertaken a detailed assessment of the effectiveness of the National Dementia Strategy, it has commissioned an independent assessment of the improvements in dementia care and support since 2009, which incorporates the progress made under both the National Dementia Strategy (2009-14) and the current Prime Minister’s Challenge on Dementia. The National Dementia Strategy was superseded by the Prime Minister's Challenge on Dementia launched in 2012, which builds on and takes forward at pace the work commenced as part of the National Dementia Strategy. The Prime Minister's Challenge concludes at the end of March 2015.</p><p> </p><p> </p><p> </p><p>The National Dementia Strategy has been the subject of more detailed work by the All Party Parliamentary Group (APPG) on Dementia and other organisations this year, which is being used to inform the Department’s work on the future of dementia care and support. The APPG published a report in May 2014, ‘Building on the National Dementia Strategy: Change, progress and priorities’.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 212686 question first answered 06/11/2014 15:27:13 answering member 1439 label Biography information for Norman Lamb
	tabling member	4022 label Biography information for Oliver Colvile

169514

	registered interest
	date	10/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Blood: Contamination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to maximise the coverage of testing for (a) hepatitis C and (b) other blood-borne viruses in a range of healthcare settings.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	218029
	answer	answer is ministerial correction date of answer 17/12/2014 answer text <p>Public Health England (PHE) has undertaken various activities to increase the number of people tested for blood-borne viruses (BBV) including contributing to and developing a range of guidance:</p><p> </p><p>- The National Institute for Health and Care Excellence (NICE) guidance to promote and offer testing for hepatitis B and C [1]</p><p> </p><p>- Best practice guidance on hepatitis B antenatal screening and the newborn immunisation programme [2]</p><p> </p><p>- NICE guidance on increasing human immunodeficiency virus (HIV) testing among Men who have Sex with Men (MSM) [3] and Black African [4] communities in a variety of community and medical settings.</p><p> </p><p>- An offer of antenatal HIV screening is recommended for all pregnant women [5].</p><p> </p><p>- Piloting models of service delivery and exploiting novel testing methods, including point of care testing and alternatives to venepuncture to test for HIV, hepatitis B and C in community settings.</p><p> </p><p>- Working collaboratively with the National Health Service and non-governmental organisations to advocate for increased uptake of screening for BBV and monitoring testing uptake of BBV in the United Kingdom [6],[7].</p><p> </p><p> </p><p> </p><p><em>Notes:</em></p><p> </p><p>[1] Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection; Issued: December 2012 last modified: March 2013 NICE public health guidance 43 <a href="http://publications.nice.org.uk/hepatitis-b-and-c-ways-to-promote-and-offer-testing-to-people-at-increased-risk-of-infection-ph43/considerations" target="_blank">http://publications.nice.org.uk/hepatitis-b-and-c-ways-to-promote-and-offer-testing-to-people-at-increased-risk-of-infection-ph43/considerations</a></p><p> </p><p>[2] Department of Health. Hepatitis B antenatal screening and newborn immunisation programme: Best practice guidance 2011 www.gov.uk/government/uploads/system/uploads/attachment_data/file/215622/dh_132637.pdf</p><p> </p><p>[3] Increasing the uptake of HIV testing among Men who have Sex with Men. NICE public health guidance 34 <a href="http://www.nice.org.uk/guidance/ph34/resources/guidance-increasing-the-uptake-of-hiv-testing-among-men-who-have-sex-with-men-pdf" target="_blank">http://www.nice.org.uk/guidance/ph34/resources/guidance-increasing-the-uptake-of-hiv-testing-among-men-who-have-sex-with-men-pdf</a></p><p> </p><p>[4] Increasing the uptake of HIV testing among black Africans in England NICE public health guidance 33 <a href="http://www.nice.org.uk/guidance/ph33/resources/guidance-increasing-the-uptake-of-hiv-testing-among-black-africans-in-england-pdf" target="_blank">http://www.nice.org.uk/guidance/ph33/resources/guidance-increasing-the-uptake-of-hiv-testing-among-black-africans-in-england-pdf</a></p><p> </p><p>[5] Yin Z et al. HIV in the United Kingdom 2014 Report: data to end 2013. November 2014. Public Health England, London. <a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377194/2014_PHE_HIV_annual_report_19_11_2014.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377194/2014_PHE_HIV_annual_report_19_11_2014.pdf</a></p><p> </p><p>[6] Public Health England. Hepatitis C in the UK: 2014 Report. <a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337115/HCV_in_the_UK_2014_24_July.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337115/HCV_in_the_UK_2014_24_July.pdf</a></p><p> </p><p>[7] Public Health England. HIV in the UK: 2014 Report <a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377194/2014_PHE_HIV_annual_report_19_11_2014.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/377194/2014_PHE_HIV_annual_report_19_11_2014.pdf</a></p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/12/2014 16:36:45 answering member 3918 label Biography information for Jane Ellison
	tabling member	4022 label Biography information for Oliver Colvile

169769

	registered interest
	date	11/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Autism
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many local authorities have an autism strategy.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	218270
	answer	answer is ministerial correction date of answer 17/12/2014 answer text <p>This information is not recorded centrally. Local joint commissioning plans for services for adults with autism should be developed and updated based on effective joint strategic needs assessment. The second national Public Health England self-assessment exercise reported on progress being made by the end of September 2013 across all 152 local authority areas in England.</p><p> </p><p><br> Details can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.ihal.org.uk/projects/autism2013" target="_blank">www.ihal.org.uk/projects/autism2013</a></p><p> </p><p> </p><p> </p><p>The exercise is a key means of identifying progress in implementing the strategy as a whole and for demonstrating local accountability. The most recent exercise started on 12 December 2014 for completion by 9 March 2015.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 17/12/2014 17:42:56 answering member 1439 label Biography information for Norman Lamb
	tabling member	4022 label Biography information for Oliver Colvile

49356

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what his policy is on the licensing of e-cigarettes.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	197421
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p /> <p /> <p>On 14 March 2014, European Union member states formally adopted the revised Tobacco Products Directive, including the provisions for regulation of electronic cigarettes. Article 18 of the Directive will subject electronic cigarettes to consumer products legislation, with specific additional regulatory requirements unless they fall under the definition of a medicinal product.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency is continuing to focus on regulating medicinal nicotine containing products, including electronic cigarettes, to enable licensed products that meet appropriate standards of safety, quality and efficacy to be available. Marketing authorisation applications have been submitted and interest in licensing continues.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197422 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4022 label Biography information for Oliver Colvile

49357

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department has given consideration to licensing e-cigarettes as medicines.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	197422
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p /> <p /> <p>On 14 March 2014, European Union member states formally adopted the revised Tobacco Products Directive, including the provisions for regulation of electronic cigarettes. Article 18 of the Directive will subject electronic cigarettes to consumer products legislation, with specific additional regulatory requirements unless they fall under the definition of a medicinal product.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency is continuing to focus on regulating medicinal nicotine containing products, including electronic cigarettes, to enable licensed products that meet appropriate standards of safety, quality and efficacy to be available. Marketing authorisation applications have been submitted and interest in licensing continues.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197421 question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4022 label Biography information for Oliver Colvile

49358

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if his Department will put restrictions in place to prevent the promotion of e-cigarettes to people under the age of 16 years.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	197423
	answer	answer is ministerial correction date of answer 06/05/2014 answer text <p>The revised Tobacco Products Directive (Directive 2014/40/EU) will prohibit the advertising of e-cigarettes marketed as consumer electronic products where there is a cross-border dimension, for example television, radio, newspapers and magazines. The Department will consult on the transposition of the Directive into United Kingdom law and seek views on the need for domestic provisions on advertising.</p><p> </p><p>It was not possible to achieve age of sale controls through the revised Directive so the Government has already moved quickly to take regulation-making powers for Ministers in England and Wales to prohibit the sale of e-cigarettes to under-18s, through the Children and Families Act. In England, we plan to bring this new law into effect within the current Parliament.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4022 label Biography information for Oliver Colvile

58513

	registered interest
	date	05/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the changes in the level of access to prostate cancer treatments since 2010.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Oliver Colvile
	uin	199302
	answer	answer is ministerial correction date of answer 10/06/2014 answer text <p>The NHS England Specialised Commissioning team introduced nationally developed service specifications for a range of areas, including prostate cancer, during 2013-14. Prior to 2013, prostate cancer was routinely commissioned by primary care trusts, and as such an assessment of the changes in the level of access to prostate cancer treatments since 2010 is not technically feasible.</p><p> </p><p>Routinely commissioned treatments for prostate cancer are: (i) radical prostatectomy; (ii) radical external beam radiotherapy; and (iii) radical brachytherapy. In addition, NHS England routinely commissions systemic treatments for prostate cancer, including hormone therapy and chemotherapy.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) has published technology appraisal guidance which recommends docetaxel (Taxotere) for hormone-refractory prostate cancer and abiraterone (Zytiga), in combination with prednisolone or prednisone, for castration-resistant metastatic prostate cancer previously treated with one docetaxel-containing regimen. NICE is also currently developing technology appraisal guidance on a number of other drugs for prostate cancer.</p><p> </p><p>National Health Service commissioners are legally required by regulations to fund those treatments recommended by NICE in its technology appraisal guidance.</p><p> </p><p>Five-year survival rates improved from around 42% in the late 1980s to 79.7% in 2007 (currently 80.2% according to data for 2006-2010 published in October 2012) due in part to the effects of increased Prostate Specific Antigen testing and earlier detection. However, survival rates in England are still lagging behind comparable countries in Europe.</p><p> </p><p>Cancer Research UK has estimated that men with advanced, incurable prostate cancer treated in trials or under drug access schemes at the Royal Marsden Hospital survived on average 41 months, compared to between 13 and 16 months 10 years ago.</p><p> </p><p>The Government's Mandate to NHS England sets out an ambition to make England one of the most successful countries in Europe at preventing premature deaths from all cancers, including prostate cancer. Cancer indicators in the NHS Outcomes Framework and the Public Health Outcomes Framework will help NHS England to assess progress in improving cancer survival and mortality for men with prostate cancer.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 199303 199304 question first answered 10/06/2014 15:28:08 answering member 3918 label Biography information for Jane Ellison
	tabling member	4022 label Biography information for Oliver Colvile